| Wylie Leroy Barnes, ACNP | |
|
1118 S Penn St, Aberdeen, SD 57401-7232 | |
| (605) 290-7951 | |
| Not Available |
| Full Name | Wylie Leroy Barnes |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1118 S Penn St, Aberdeen, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649744822 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | CP001509 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera St Lukes | Aberdeen, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Avera St Lukes | 6406764927 | 132 |
News Archive
Tracking the genetic pathway of a disease offers a powerful, new approach to drug discovery, according to scientists at the University of California, San Diego School of Medicine who used the approach to uncover a potential treatment for prostate cancer, using a drug currently marketed for congestive heart failure. Their findings are published in the current online issue of the Proceedings of the National Academy of Sciences.
A new online system, developed by the University of Sheffield, which enables healthcare professionals to remotely monitor and support patients who have motor neurone disease (MND) during the Covid-19 pandemic, has been fast-tracked for use by Sheffield Teaching Hospitals.
Today, PLoS Medicine places in the public domain all documents - around 1500 - released after the journal and The New York Times intervention in the Prempro case. The documents, are available on the PLoS Medicine website, and are uploaded in the form that PLoS received them from the court.
MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that the company's Irvine, California, CLIA laboratory has received College of American Pathology (CAP) accreditation.
Heart failure affects roughly six million Americans, yet treatment consists of either a heart transplant or the insertion of mechanical devices that assist the heart. This is unacceptable to Roberto Bolli, MD, Chief of the Division of Cardiovascular Medicine at the University of Louisville in Louisville, Ky., which is why he is on a mission to make cardiac stem cell treatment an option for all who must cope with the limitations of a failing heart.
› Verified 7 days ago
| Entity Name | Avera St Lukes |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215100813 PECOS PAC ID: 6406764927 Enrollment ID: O20040120000912 |
News Archive
Tracking the genetic pathway of a disease offers a powerful, new approach to drug discovery, according to scientists at the University of California, San Diego School of Medicine who used the approach to uncover a potential treatment for prostate cancer, using a drug currently marketed for congestive heart failure. Their findings are published in the current online issue of the Proceedings of the National Academy of Sciences.
A new online system, developed by the University of Sheffield, which enables healthcare professionals to remotely monitor and support patients who have motor neurone disease (MND) during the Covid-19 pandemic, has been fast-tracked for use by Sheffield Teaching Hospitals.
Today, PLoS Medicine places in the public domain all documents - around 1500 - released after the journal and The New York Times intervention in the Prempro case. The documents, are available on the PLoS Medicine website, and are uploaded in the form that PLoS received them from the court.
MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that the company's Irvine, California, CLIA laboratory has received College of American Pathology (CAP) accreditation.
Heart failure affects roughly six million Americans, yet treatment consists of either a heart transplant or the insertion of mechanical devices that assist the heart. This is unacceptable to Roberto Bolli, MD, Chief of the Division of Cardiovascular Medicine at the University of Louisville in Louisville, Ky., which is why he is on a mission to make cardiac stem cell treatment an option for all who must cope with the limitations of a failing heart.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wylie Leroy Barnes, ACNP 1118 S Penn St, Aberdeen, SD 57401-7232 Ph: (605) 290-7951 | Wylie Leroy Barnes, ACNP 1118 S Penn St, Aberdeen, SD 57401-7232 Ph: (605) 290-7951 |
News Archive
Tracking the genetic pathway of a disease offers a powerful, new approach to drug discovery, according to scientists at the University of California, San Diego School of Medicine who used the approach to uncover a potential treatment for prostate cancer, using a drug currently marketed for congestive heart failure. Their findings are published in the current online issue of the Proceedings of the National Academy of Sciences.
A new online system, developed by the University of Sheffield, which enables healthcare professionals to remotely monitor and support patients who have motor neurone disease (MND) during the Covid-19 pandemic, has been fast-tracked for use by Sheffield Teaching Hospitals.
Today, PLoS Medicine places in the public domain all documents - around 1500 - released after the journal and The New York Times intervention in the Prempro case. The documents, are available on the PLoS Medicine website, and are uploaded in the form that PLoS received them from the court.
MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that the company's Irvine, California, CLIA laboratory has received College of American Pathology (CAP) accreditation.
Heart failure affects roughly six million Americans, yet treatment consists of either a heart transplant or the insertion of mechanical devices that assist the heart. This is unacceptable to Roberto Bolli, MD, Chief of the Division of Cardiovascular Medicine at the University of Louisville in Louisville, Ky., which is why he is on a mission to make cardiac stem cell treatment an option for all who must cope with the limitations of a failing heart.
› Verified 7 days ago
Ashley Marie Landis, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 701 8th Ave Nw, Suite A, Aberdeen, SD 57401 Phone: 605-226-2663 | |
Lindsay Habeck, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3015 3rd Ave Se, Aberdeen, SD 57401 Phone: 605-226-5500 | |
Matthew R Lutjens, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 105 S State St Ste 113, Aberdeen, SD 57401 Phone: 605-225-0378 Fax: 605-225-7919 | |
Ms. Valerie Anne Jones, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1315 6th Ave Se, Suite 6, Aberdeen, SD 57401 Phone: 605-225-1538 Fax: 605-229-2053 | |
Kristine Lynn Fastenau, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 310 S Penn St Ste 203, Aberdeen, SD 57401 Phone: 605-225-7326 | |
Alisa Hogue, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 310 S Penn St, Suite 202, Aberdeen, SD 57401 Phone: 605-622-2895 Fax: 605-622-2896 | |
Sara Hegg, CNP, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2120 8th Ave Ne, Aberdeen, SD 57401 Phone: 605-725-4772 Fax: 605-725-4777 |